Life Science Company News

Results 181 - 200 out of 500 displayed.

By: PR Newswire Association LLC. - 03 Oct 2024

Related companies: NYU Langone Health | NYU Langone Medical Center- Cytometry & Cell Sorting Laboratory

FDA grants Breakthrough Device designation to Amphix Bio's bone regeneration product

By: PR Newswire Association LLC. - 03 Oct 2024

U.S. Dermatology Partners Announces the Opening of San Augustine, Texas Office

By: PR Newswire Association LLC. - 03 Oct 2024

Related companies: Clear Dermatology | Department of Dermatology, UC San Diego Health Sciences | Encore Dermatology, Inc.

Hip Replacement Implants Market is expected to generate a revenue of USD 8.44 Billion by 2031, Globally, at 3.94% CAGR: Verified Market Research®

By: PR Newswire Association LLC. - 03 Oct 2024

Custom Foot Orthotic Insoles Market Projected to Reach $5.2 Billion by 2031, Driven by Technological Advancements and Growing Foot Health Awareness: Market Research Intellect

By: PR Newswire Association LLC. - 03 Oct 2024

Medical Grade Silicone Market Surges to USD 3.6 Billion by 2030, Propelled by 5.7% CAGR - Verified Market Reports®

By: PR Newswire Association LLC. - 03 Oct 2024

Dental Drills & Burs Market Set for Significant Expansion Projected to Reach USD 1.2 Billion by 2031 Driven by Technological Advancements and Increasing Demand: Market Research Intellect

By: PR Newswire Association LLC. - 03 Oct 2024

Clinical Trial Imaging Market to Hit USD 2.07 Billion by 2029 with 7.8% CAGR | MarketsandMarkets™

By: PR Newswire Association LLC. - 03 Oct 2024

ZINZINO AB (PUBL): PRELIMINARY SALES REPORT Q3 2024

By: PR Newswire Association LLC. - 03 Oct 2024

Eton Pharmaceuticals, Inc to Acquire Increlex® (mecasermin injection) from Ipsen

By: GlobeNewswire - 03 Oct 2024

Related companies: Eton Pharmaceuticals, Inc.

Pharvaris Announces Data Highlighting Deucrictibant for the Treatment of HAE to be Presented at the 2024 HAEi Global Leadership Workshop

By: GlobeNewswire - 03 Oct 2024

Related companies: Pharvaris GmbH

CytoMed Therapeutics completes cash acquisition of Cord Blood Banking Licence and Assets expanding CytoMed’s strategy to cord blood-derived biologics through subsidiary, LongevityBank

By: GlobeNewswire - 03 Oct 2024

Related companies: CytoMed Therapeutics Pte Ltd

First Patient Dosed in Phase II ‘CA-NINE’ Trial of TLX250-CDx for Detection of Recurrent Kidney Cancer After Surgery

By: GlobeNewswire - 03 Oct 2024

Related companies: Telix Pharmaceuticals Limited

Microbix Achieves Essential EU Regulatory Accreditations

By: GlobeNewswire - 03 Oct 2024

Related companies: Microbix Biosystems Inc. | MBX Biosciences, Inc.

Better Choice Company and SRx Health to Host Shareholder Update Call on October 15th

By: GlobeNewswire - 03 Oct 2024

BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

By: GlobeNewswire - 03 Oct 2024

Related companies: BioCryst Pharmaceuticals, Inc.

BridgeBio to Present Outcomes Data Through 42 Months from the Open-Label Extension of ATTRibute-CM, the Phase 3 Study of Acoramidis for Treatment of ATTR-CM, at 2024 AHA Scientific Sessions

By: GlobeNewswire - 03 Oct 2024

Related companies: BridgeBio Inc.

Legend Biotech to Establish New, State-of-the-Art Cell Therapy Research and Development Facility in Philadelphia

By: GlobeNewswire - 03 Oct 2024

Related companies: Legend Biotech USA, Inc.

Closes Units for Debt Settlement

By: GlobeNewswire - 03 Oct 2024

Related companies: Arch Biopartners, Inc.

Spectral Medical Provides September Tigris Trial Update

By: GlobeNewswire - 03 Oct 2024

Related companies: Spectral Medical Inc.

Results 181 - 200 out of 500 displayed.

« 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 »

Enhance your business development with Biotechgate

Try for free »